Table 3.

Patient characteristics by treatment group at the German center

	Darbepoetin alfa 500 μg Q3W (n=50)	Binocrit® 40,000 IU QW (n=95)
Mean (SD) age, years	55.6 (11.20)	56.9 (11.95)
Tumor type, n (%)
Breast	41 (82.0)	81 (85.2)
Ovarian	4 (9.8)	8 (8.4)
Cervical	2 (4.0)	4 (4.2)
Other	3 (6.0)	2 (2.1)

Note: Binocrit^® (Sandoz GmbH, Kundl, Austria).

Abbreviations: QW, once weekly; Q3W, once every 3 weeks; SD, standard deviation.